Ads
related to: hepatitis c antibody reactive abnormal range- Dosage & Administration
Get Dosage & Administration Info
For A Pangenotypic Treatment Option
- Clinical Study Designs
Learn More About The Study Designs
For A Pangenotypic Treatment Option
- Clinical Study Results
Read About Study Results For A
Pangenotypic Hep C Treatment Option
- Patient Site
Considering Treatment? Visit The
Official Patient Site To Learn More
- Access & Resources
Help Your Patients Access A
Pangenotypic Hep C Treatment Option
- Safety Information
Find Out More About Safety Info
For A Pangenotypic Treatment Option
- Dosage & Administration
Search results
Results From The WOW.Com Content Network
Chronic hepatitis C is defined as infection with the hepatitis C virus persisting for more than six months based on the presence of its RNA. [18] Chronic infections are typically asymptomatic during the first few decades, [ 18 ] and thus are most commonly discovered following the investigation of elevated liver enzyme levels or during a routine ...
In a nutshell, “hepatitis C is a virus that infects the liver, causing inflammation and scarring of the organ,” says K. V. Narayanan Menon, MD, the medical director of liver transplantation at ...
Chronic hepatitis C progresses towards cirrhosis, with estimates of cirrhosis prevalence of 16% at 20 years after infection. [126] While the major causes of mortality in hepatitis C is end stage liver disease, hepatocellular carcinoma is an important additional long term complication and cause of death in chronic hepatitis.
Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed.
Secondary cold agglutinin syndrome occurs when autoantibodies bind to red blood cells, rendering them subject to attack by the complement system. [17] It is a result of an underlying condition potentially associated with either monoclonal cold-reacting autoantibodies or polyclonal cold-reacting autoantibodies [16] predominantly caused by infection or lymphoproliferative disorders. [16]
Normal ranges for both ALT and AST vary by gender, age, and geography and are roughly 8-40 U/L (0.14-0.67 μkal/L). [4] Mild transaminesemia refers to levels up to 250 U/L. [ 1 ] Drug-induced increases such as that found with the use of anti-tuberculosis agents such as isoniazid are limited typically to below 100 U/L for either ALT or AST.
Ad
related to: hepatitis c antibody reactive abnormal range